Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization

doi:10.12998/wjcc.v8.i16.3493

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4309)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-5) series.

Item

Count

PDF

239

WORD

222

HTML

1957

Tables (1-5)

214

Sum=2632

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

619

Download

1058

Sum=1677

Aug 26, 2020 (publication date) through Jul 17, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Aug 26, 2020; 8(16): 3493-3502
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3493

Table 1 Efficacy of transcatheter arterial chemoembolization in different types of hepatocellular carcinoma, n (%)

Group	n	CR (%)	PR (%)	SD (%)	PD (%)
Massive type	71	0	17 (23.94)	41 (57.75)	13 (18.31)
Nodular type	80	0	13 (16.25)	34 (42.50)	33 (41.25)
Diffuse type	11	0	0	7 (63.64)	4 (36.36)

CR: Complete remission; PR: Partial remission; SD: Stable disease; PD: Disease progression.

Citation: Guo Z, Wang J, Li L, Liu R, Fang J, Tie B. Value of miR-1271 and glypican-3 in evaluating the prognosis of patients with hepatocellular carcinoma after transcatheter arterial chemoembolization. World J Clin Cases 2020; 8(16): 3493-3502
URL: https://www.wjgnet.com/2307-8960/full/v8/i16/3493.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i16.3493